Highest-materiality recent filing
Ingredion names Diego Reynoso as CFO, effective Oct 1, 2026
Reynoso, formerly Boston Beer CFO, becomes EVP & CFO on Oct 1, 2026.
Ingredion Q2 adjusted EPS $2.82, reaffirms guidance; Tate & Lyle acquisition approved
Q2 reported EPS $1.78, adjusted EPS $2.82; reported operating income down 31%, adjusted down 5% vs Q2 2025.
Ingredion appoints director Kenneth Escoe to Audit Committee
Kenneth Escoe appointed to Audit Committee of the Board.
Tate & Lyle shareholders approve Ingredion's all-cash acquisition
Tate & Lyle shareholders voted to approve the scheme of arrangement on July 28, 2026.
Ingredion's acquisition of Tate & Lyle advances; shareholder meetings set for July 28, 2026
Tate & Lyle published the Scheme Document on July 3, 2026, detailing the recommended cash acquisition by Ingredion.
Ingredion completes sale of 51% stake in Rafhan Maize for $165M to Nishat Group
Ingredion sold 51% of Rafhan Maize to Nishat Hotels and Properties Ltd. for ~$165M cash.
Ingredion enters $1.475B delayed draw term loan to fund Tate & Lyle acquisition
Committed $1.475B delayed draw term loan, split $500M Tranche A-1 and $975M Tranche B-1.
Ingredion elects Kenneth Escoe to board effective July 1, 2026
Kenneth Escoe, age 51, elected to board effective July 1, 2026.
Ingredion agrees to acquire Tate & Lyle for £2.7B ($3.6B) in cash
Cash consideration of 595 pence per Tate & Lyle share; total enterprise value ~£2.7B ($3.6B).
Stockholders elect all 11 directors, approve say-on-pay, and ratify KPMG as auditor
All 11 director nominees elected; votes for ranged from 46.7M (James Zallie) to 50.9M (Siobhán Talbot); broker non-votes ~4.3M.
Ingredion announces non-binding all-cash offer for Tate & Lyle at 595p/share
Offer price: 595 pence per Tate & Lyle share, all cash.
Ingredion Q1 EPS $2.22 adj $2.34, down from $3.00/$2.97; guides FY adj EPS $10.45-$11.15
Q1 2026 reported EPS $2.22, adjusted $2.34 vs Q1 2025 $3.00 and $2.97 respectively.
Ingredion to close Cabo, Brazil plant; expects $43M in pre-tax charges
Cessation of operations at Cabo, Brazil manufacturing facility effective June 30, 2026.
Ingredion appoints Jason Payant as Interim CFO effective April 1, 2026
Jason Payant, 55, appointed Interim CFO effective April 1, 2026, succeeding James D. Gray who resigned March 31.
Ingredion board member Kenny retires; Siobhán Talbot elected director
Gregory B. Kenny notified Ingredion on March 20, 2026 of retirement from the Board, effective March 23, 2026.
Ingredion appoints CEO James P. Zallie as Chairman; Victoria J. Reich elected Lead Director
CEO James P. Zallie appointed Chairman of the Board effective February 9, 2026.
Ingredion reports FY2025 EPS $11.18 (adj. $11.13); guides FY2026 $11.00-$11.80
FY2025 reported EPS $11.18, adjusted EPS $11.13 vs $9.71 and $10.65 in FY2024.
Ingredion CFO James Gray to retire effective March 31, 2026
James Gray, EVP and CFO, notified Ingredion of his retirement on Jan 26, 2026, effective March 31, 2026.
Ingredion Q3 2025 EPS $2.61; operating income down 7% YoY; full-year guidance adjusted
Q3 2025 reported EPS $2.61; adjusted EPS $2.75; Q3 2024 was $2.83 and $3.05 respectively.
Ingredion approves new stock repurchase program of up to 8 million shares
Board terminated existing program with 2.1M shares remaining; new authorization up to 8M shares.
Ingredion to divest 51% of Rafhan Maize to Nishat Group, retains 20%
Ingredion sells 51% ownership interest in Pakistan affiliate Rafhan Maize to Nishat Group.
Ingredion enters $1.0B five-year revolving credit facility, replacing prior facility
$1.0B unsecured revolving credit facility maturing August 27, 2030; no borrowings drawn at closing.
Ingredion Q2 EPS $2.99; FY EPS guidance raised to $11.25-$11.75
Q2 2025 reported EPS $2.99 vs $2.22 prior year; adjusted EPS $2.87 flat YoY.
Ingredion announces results of 2025 annual meeting; all proposals approved
Shareholders elected all 11 director nominees; David B. Fisher received 52,132,151 votes for.
Ingredion Q1 adjusted EPS $2.97 beats prior year; raises full-year guidance
First-quarter reported EPS $3.00, adjusted EPS $2.97; adjusted operating income up 26% YoY.
On May 2, 2025, Rafhan Maize filed a notice that Ingredion is exploring selling its majority control.
Ingredion FY2024 adj. EPS $10.65 vs $9.42; guides FY2025 EPS $10.75-$11.55
Full-year 2024 reported EPS $9.71, adjusted EPS $10.65; prior year $9.60 and $9.42.
Ingredion to cease operations at Vanscoy plant protein facility; expects ~$66M pre-tax charges
Ceasing operations at Vanscoy, Saskatchewan plant protein concentrates and flour facility effective Jan 6, 2025, after strategic review.
Ingredion holds Texture Innovation Day presentation, no material financial updates disclosed
Filed under Item 7.01; presentation furnished as Exhibit 99 on November 14, 2024.
Ingredion Q3 adjusted EPS $3.05, up 31%; raises full-year guidance
Q3 reported EPS $2.83 (+20% YoY); adjusted EPS $3.05 (+31% YoY).
Ingredion Q2 adjusted EPS $2.87 (+24% YoY); raises FY2024 EPS guidance
Reported EPS $2.22 (down 8% YoY); adjusted EPS $2.87 (up 24% YoY).
Ingredion adopts new executive severance and change-in-control pay plans for Section 16 officers
CEO gets 2X base salary + target bonus over 24 months in severance; 3X lump-sum in change of control.
Ingredion shareholders elect 11 directors, approve charter amendment limiting officer liability
All 11 director nominees elected: votes for between 50.1M and 53.8M each (excluding broker non-votes).
Ingredion completes S.Korea sale; Q1 adj. EPS $2.08 (-26% YoY); raises FY 2024 guidance
Reported Q1 EPS of $3.23 (+13% YoY); adjusted EPS $2.08 (-26% YoY).
Ingredion SVP & Chief Innovation Officer Jeremy Xu resigns effective April 8, 2024
Jeremy Xu resigns effective April 8, 2024; notified Ingredion on Feb 22.
Ingredion reports FY2023 adjusted EPS $9.42 (+26% YoY); guides FY2024 adjusted EPS $9.15-$9.85
Q4 2023 reported operating income up 29% YoY; adjusted operating income up 21% YoY.
Ingredion to sell South Korea business to Sajo Group affiliate; close expected Q1 2024
Ingredion entered definitive agreement to divest its South Korea operations to an affiliate of Sajo Group.
Ingredion Q3 EPS $2.36, adjusted EPS $2.33; raises FY adjusted EPS outlook to $9.05-$9.45
Reported EPS $2.36 (+48% YoY); adjusted EPS $2.33 (+35% YoY).
Ingredion to reorganize business globally, change reporting segments in Q1 2024
Reorganization shifts from regional to dual global/local focus, targeting texture and healthful solutions globally.
Director Paul Hanrahan to retire from Ingredion Board effective October 28, 2023
Paul Hanrahan notified Ingredion of his retirement from the Board on Sept 15, 2023, effective Oct 28, 2023.
Ingredion Q2 EPS $2.42 adjusted $2.32; raises FY adjusted EPS outlook to $8.80-$9.40
Reported EPS $2.42, up 14% YoY; adjusted EPS $2.32, up 9% YoY.
Ingredion shareholders approve 2023 Stock Incentive Plan; elect 12 directors
Plan authorizes up to 3.1M new shares plus shares remaining from prior plan for equity awards.
Record Q1: adj EPS $2.80 vs $1.95, margins up 280bps; FY guide raised to $8.70-9.40
Q1 reported EPS $2.85, adjusted EPS $2.80, vs $1.92 and $1.95 in Q1 2022.
Ingredion EVP & President Americas Jorgen Kokke resigns effective May 1, 2023
Jorgen Kokke notified Ingredion of resignation from EVP and President, Americas roles.
Ingredion Q4 2022 net sales +13%, adj. EPS $1.65; guides FY2023 $7.70-$8.40
Q4 2022 reported EPS $1.71; adjusted EPS $1.65 vs $1.09 in Q4 2021.
Ingredion enters $200M 24-month term loan with PNC, repays existing debt
Borrowed $200M under senior unsecured term loan on Dec 16, 2022; matures Dec 16, 2024.
Ingredion Q3 adjusted EPS $1.73, raises FY2022 outlook to $7.00-$7.45
Q3 net sales $2,023M, up 15% reported, 19% ex-FX vs Q3 2021.
Ingredion authorizes 6M share repurchase program through 2025; declares $0.71 quarterly dividend
New repurchase authorizes up to 6 million shares from Sept 26, 2022 through Dec 31, 2025.
Ingredion amends bylaws with exclusive forum provisions and enhanced stockholder meeting rules
Adopted exclusive forum for derivative, fiduciary duty, and Securities Act claims in Delaware courts.
Ingredion Q2 adjusted EPS $2.12 vs $2.05 YoY; net sales up 16%
Q2 2022 reported and adjusted EPS $2.12; Q2 2021 reported $2.62, adjusted $2.05.
the Company’s Board elected Kenneth Escoe to serve as a director of the Company, with a term beginning effective July 1, 2026.
On February 22, 2024, Jeremy Xu, Senior Vice President, Chief Innovation Officer and President, Global Healthful Solutions of Ingredion Incorporated, notified Ingredion Incorporated that he will resign from such positions effective April 8, 2024.
On September 15, 2023, director Paul Hanrahan informed Ingredion Incorporated (the “Company”) of his decision to retire from the Company’s Board of Directors following his assumption of the role of Chairman of Cubico Sustainable Investments, a private company in the U.K..
On March 31, 2023, Jorgen Kokke, Executive Vice President and President, Americas of Ingredion Incorporated, notified Ingredion Incorporated that he will resign from such positions effective May 1, 2023.
On January 12, 2022, director Barbara A. Klein informed Ingredion Incorporated (the “Company”) of her decision to retire from the Company’s Board of Directors effective February 17, 2022.
On December 16, 2021, the Board of Directors (the “Board”) of Ingredion Incorporated (the “Company”) elected Charles V. (“Chuck”) Magro a director of the Company, effective May 1, 2022.
James D. Gray, the Company’s Executive Vice President and Chief Financial Officer, was removed from the position of principal accounting officer of Ingredion Incorporated (the “Company”), effective as of that date.
the Company’s Board of Directors appointed Davida M. Gable, the Company’s Vice President, Controller and Global Shared Services, to succeed Mr. Gray as the Company’s principal accounting officer, effective as of that date.
On August 20, 2021, Elizabeth Adefioye, Senior Vice President and Chief Human Resources Officer of Ingredion Incorporated (the “Company”), advised the Company she will resign from all such positions effective October 13, 2021.
On August 17, 2021, the Board of Directors (the “Board”) of Ingredion Incorporated (the “Company”) elected Catherine A. Suever a director of the Company, effective August 17, 2021.
Janet M. Bawcom, Senior Vice President, General Counsel, Corporate Secretary and Chief Compliance Officer of Ingredion Incorporated (the “Company”), has advised the Company she will resign from all such positions effective July 1, 2021.
Max materiality 0.90 · Median 0.65 · Most common event earnings